Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: A randomized trial

Therapeutic Advances in Gastroenterology

Volumn 6, Issue 4, 2013, Pages 249-259

  Eckard, Carly ^a   Cole, Renee ^a   Lockwood, Joshua ^b   Torres, Dawn M ^c   Williams, Christopher D ^d   Shaw, Janet C ^e   Harrison, Stephen A ^d  

^a Army Medical Department Center and School   (United States)

^b WOMACK ARMY MEDICAL CENTER   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d BROOKE ARMY MEDICAL CENTER   (United States)

^e WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

diabetes; diet; fatty liver; lifestyle modification; low fat; NAFLD; treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; INSULIN; LIPID;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD EXAMINATION; BODY COMPOSITION; BODY WEIGHT; CARBOHYDRATE DIET; CONTROLLED STUDY; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; EVALUATION; EXERCISE; FAT MASS; FEMALE; FITNESS; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; LIVER BIOPSY; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

EID: 84878330831     PISSN: 1756283X     EISSN: 17562648     Source Type: Journal    
DOI: 10.1177/1756283X13484078     Document Type: Article

References (48)

1. Angulo P. Hui J. Marchesini G. Bugianesi E. George J. Farrell G. (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45: 846–854.
2. Bellentani S. Dalle Grave R. Suppini A. Marchesini G. (2008) Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology 47: 746–754.
3. Bellentani S. Marino M. (2009) Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol 8: S4–S8.
4. Brunt E. (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467–2474.
5. Cankurtaran M. Tayfur O. Yavuz B. Geyik S. Akhan O. Arslan S. (2007) Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention. Acta Gastroenterol Belg 70: 253–259.
6. Chen S. Liu C. Li S. Huang H. Tsai C. Jou H. et al. (2008) Effects of therapeutic lifestyle program on ultrasound-diagnosed nonalcoholic fatty liver disease. J Clin Med Assoc 71: 551–558.
7. Cinar K. Coban S. Idilman R. Tuzun A. Sarioglu M. Bektas M. et al. (2006) Long-term prognosis of nonalcoholic fatty liver disease: is pharmacological therapy actually necessary? J Gastroenterol Hepatol 21: 169–173.
8. de Luis D. Aller R. Izaola O. Sagrado M. Conde R. Gonzalez J. (2008) Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. Diabetes Res Clin Pract 79: 74–78.
9. Fletcher B. Berra K. Ades P. Braun L. Burke L. Durstine J. et al. (2005) Managing abnormal blood lipids; a collaborative approach. Circulation 112: 3184–3209.
10. Gholam P. Flancbaum L. Machan J. Charney D. Kotler D. (2007) Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol 102: 399–408.
11. Harrison S. Day C. (2007) Benefits of lifestyle modification in NAFLD. Gut 56: 1760–1769.
12. Hickman I. Jonsson J. Prins J. Ash S. Purdie D. Clouston A. et al. (2004) Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 53: 413–419.
13. Hrebicek J. Janout V. Malincikova J. Horakova D. Cizek L. (2002) Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 87: 144–147.
14. Huang M. Greenson J. Chao C. Anderson L. Peterman D. Jacobson J. et al. (2005) One-year intense nutritional counseling results in histological improvement in patients with nonalcoholic steatohepatitis: a pilot study. Am J Gasteroenterol 100: 1072–1081.
15. Kaminsky L. (2006) American College of Sports Medicine's Guidelines for Exercise Testing and Prescription. 5th ed. Philadelphia, PA: Lippincott, Williams & Wilkins.
16. Kechagias S. Ernersson A. Dahlqvist O. Lundberg P. Lindstrom T. Nystrom F. (2008) Fast food based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 57: 649–654.
17. Kleiner D. Brunt E. van Natta M. Behling C. Contos M. Cummings O. et al. (2005) Design and validation of histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313–1321.
18. Lindor K. Kowdley K. Heathcote E. Harrison M. Jorgensen R. Angulo P. et al. (2004) Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 39: 770–778.
19. Moore J. (2010) Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc Nutr Soc 69: 211–220.
20. National Heart, Lung, and Blood Institute (2000) The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health.
21. Neuschwander-Tetri B. (2005) Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci 330: 326–335.
22. Nugent C. Younossi Z. (2007) Evaluation and management of obesity related nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 4: 432–441.
23. Ogden C. Carroll M. (2010) Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960–1962 through 2007–2008. Hyattsville, MD: Center for Disease Control and Prevention National Center for Health Statistics.
24. Peng L. Weng J. Li F. (2011) Weight reduction for non-alcoholic fatty liver disease. Cochrane Database Syst Rev 6: 1–32.
25. Petersen K. Dufour S. Befroy D. Lehrke M. Hendler R. Shulman G. (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54: 603–608.
26. Promrat K. Kleiner D. Niemeier H. Jackvony E. Kearns M. Wands J. et al. (2009) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51: 121–129.
27. Rafiq N. Younossi Z. (2008) Effects of weight loss on nonalcoholic fatty liver disease. Semin Liver Dis 28: 427–433.
28. Reid A. (2001) Nonalcoholic steatohepatitis. Gastroenterology 121: 710–723.
29. Rocha R. Cotrim H. Carvalho F. Siqueira A. Braga H. Freitas L. (2005) Body mass index and waist circumference in non-alcoholic fatty liver disease. J Hum Nutr Diet 18: 365–370.
30. Sato F. Tamura Y. Watada H. Kumashiro N. Igarashi Y. Uchino H. et al. (2007) Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects. J Clin Endocrinol Metab 92: 3326–3329.
31. Schwarz J. Linfoot P. Dare D. Aghajanian K. (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77: 43–50.
32. Seagle H. Strain G. Makris A. Reeves R. (2009) Position of the American Dietetic Association: weight management. J Am Diet Assoc 109: 330–346.
33. Seppala-Lindroos A. Vehkavaara S. Hakkinen A. Goto T. Westerbacka J. Sovijarvi A. et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87: 3023–3028.
34. Shaffer E. (2006) Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese. J Clin Gastroenterol 40: S44–S50.
35. Solga S. Alkhuraishe A. Clark J. Torbenson M. Greenwald A. Diehl A. et al. (2004) Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci 49: 1578–1583.
36. St George A. Bauman A. Johnston A. Farrell G. Chey T. George J. (2009) Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. J Gastroenterol Hepatol 24: 399–407.
37. Suzuki A. Lindor K. St Saver J. Lymp J. Mendes F. Muto A. et al. (2005) Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 43: 1060–1066.
38. Tamura Y. Tanaka Y. Sato F. Choi J. Watada H. Niwa M. et al. (2005) Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 90: 3191–3196.
39. Tendler D. Lin S. Yancy W. Mavropoulos J. Sylvestre P. Rockey D. et al. (2007) The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. Digest Dis Sci 52: 589–593.
40. Torres D. Williams C. Harrison S. (2012) Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 10: 837–858.
41. Toshimitsu K. Matsuura B. Ohkubo I. Niiya T. Furukawa S. Hiasa Y. et al. (2007) Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 23: 46–52.
42. Ueno T. Sugawara H. Sujaku K. Hashimoto O. Tsuji R. Tamaki S. et al. (1997) Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 27: 103–107.
43. Vilar G. Rodriguez D. Gra O. Arus S. Llanio N. Calzadilla B. et al. (2009) Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 30: 999–1009.
44. Weiss R. (2007) Fat distribution and storage: how much, where, and how? Eur J Endocrinol 157: S39–S45.
45. Westerbacka J. Lammi K. Hakkinen A. Rissanen A. Salminen I. Aro A. et al. (2005) Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90: 2804–2809.
46. Yan E. Durazo F. Tong M. Hong K. (2007) Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. Nutr Rev 65: 376–384.
47. Youssef W. McCullough A. (2002) Steatohepatitis in obese individuals. Best Prac Res Clin Gastroenterol 16: 733–747.
48. Zelber-Sagi S. Nitzan-Kaluski D. Goldsmith R. Webb M. Blendis L. Halpern Z. et al. (2007) Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 47: 711–717.